The goal of the Congenital CMV conference is to present the latest research on diagnosis and treatment, raise awareness, delineate prevention efforts, provide information about early intervention options, and disseminate family support resources in an effort to reduce the number of babies born with CMV and connect families affected by CMV with the resources they need to improve their quality of life.

Harnessing the collective expertise and passion of groups dedicated to advancement in the field of congenital CMV infection, a special community engagement forum will be held on Wednesday, September 28 to accelerate progress toward defining the most effective interventions through research. All attendees of the Congenital CMV conference are encouraged to participate in this inaugural event.

The forum has recently been awarded a grant from the Patient-Centered Outcomes Research Institute, which will provide financial support for the meeting and implementation of the action plan generated by participants.

With your help, we can reduce the number of babies born with CMV!

Planning Committee:

Sara Doutré, Karen Fowler, Gail Demmler-Harrison, Casey Judd, Mandy McClellan, Kristen Spytek, Alyson Ward, and Karl White

Advisory Committee:

Suresh Boppana, Sheila Dollard, Paul Griffiths, Albert Park, Stanley Plotkin, Bill Rawlinson, Maria Grazia Revello, Mark Schleiss, Rosemary Thackeray, and Anne Vossen

2016 CMV Conference Partners

This conference was funded in part by a cooperative agreement (U52MC04391) from the Maternal and Child Health Bureau (MCHB) of the Health Resources and Services Administration (HRSA) at the United States Department of Health and Human Services. Opinions expressed by speakers at the conference are their own and no endorsement by MCHB/HRSA is implied or expressed.